SNAI2 and hepatocellular carcinoma: Our results indicated that transfection of C/EBPα-saRNA could suppress migration and invasion of hepatoma cells, and high expression of E-cadherin and reduction of N-cadherin, Slug, and Vimentin in C/EBPα-saRNA transfected cells.